Stock EIGR EIGER BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Eiger BioPharmaceuticals, Inc.

Equities

EIGR

US28249U2042

Delayed OTC Markets
Other stock markets
 12:25:31 2024-05-16 pm EDT 		5-day change 1st Jan Change
2.24 USD -0.44% Intraday chart for Eiger BioPharmaceuticals, Inc. -0.44% -66.74%
May. 08 Sentynl Therapeutics, Inc. acquired Global rights to Zokinvy Eiger BioPharmaceuticals, Inc. (OTCPK:EIGR.Q) for $45.2 million. CI
May. 06 Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. EIGR Stock
  4. Revisions Eiger BioPharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW